Skip to main content
OpenTrials

Clinical trial condition

Human Immunodeficiency Virus Type 1

Explore clinical trials studying Human Immunodeficiency Virus Type 1. Study availability and eligibility vary by location and protocol.

8 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Human Immunodeficiency Virus Type 1 trial results

Completed

Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Regimen Versus Boosted Protease Inhibitor (bPI) Along With Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) Regimen in Virologically-Suppressed, HIV-1 Infected Participants

NCT02269917

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Phoenix, Arizona, United States
  • Bakersfield, California, United States
  • Beverly Hills, California, United States
  • Long Beach, California, United States
View all 79 locations
View Trial Details
Completed

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

NCT00540449

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • Birmingham, Alabama, United States
  • Phoenix, Arizona, United States
  • Beverly Hills, California, United States
  • Los Angeles, California, United States
View all 92 locations
View Trial Details
Completed

A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

NCT00110305

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Beverly Hills, California, United States
  • Washington D.C., District of Columbia, United States
  • Orlando, Florida, United States
  • Tampa, Florida, United States
View all 40 locations
View Trial Details

Related conditions